Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
European Journal of Endocrinology
|
March 15, 2005
Subclinical hyperthyroidism: clinical features and treatment options
Bernadette Biondi, Emiliano Antonio Palmieri, Michele Klain, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 6, 2005
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment
Leonardo Pace, Michele Klain, Carmine Albanese, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Fabio Volpe, Carmela Nappi, Emilia Zampella, et al.
Journal of Geriatric Cardiology : JGC
|
October 18, 2021
Cardiac hybrid imaging: novel tracers for novel targets
Andrea Ponsiglione, Raffaele Ascione, Carmela Nappi, et al.
Frontiers in Neurology
|
September 24, 2021
Combining Thin-Section Coronal and Axial Diffusion Weighted Imaging: Good Practice in Middle Ear Cholesteatoma Neuroimaging
Camilla Russo, Antonella Miriam Di Lullo, Elena Cantone, et al.
Clinical Endocrinology
|
March 1, 2003
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study
Carolina Di Somma, Rosario Pivonello, Sandro Loche, et al.
International Journal of Molecular Sciences
|
December 21, 2017
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer
Adelaide Greco, Luigi Auletta, Francesca Maria Orlandella, et al.
Frontiers in Endocrinology
|
April 2, 2019
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
Michele Klain, Leonardo Pace, Emilia Zampella, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2021
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
Carmela Nappi, Michele Klain, Valeria Cantoni, et al.
Endocrine
|
November 8, 2021
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives
Michele Klain, Julien Hadoux, Carmela Nappi, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
European Journal of Endocrinology
|
March 15, 2005
Subclinical hyperthyroidism: clinical features and treatment options
Bernadette Biondi, Emiliano Antonio Palmieri, Michele Klain, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 6, 2005
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment
Leonardo Pace, Michele Klain, Carmine Albanese, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Fabio Volpe, Carmela Nappi, Emilia Zampella, et al.
Journal of Geriatric Cardiology : JGC
|
October 18, 2021
Cardiac hybrid imaging: novel tracers for novel targets
Andrea Ponsiglione, Raffaele Ascione, Carmela Nappi, et al.
Frontiers in Neurology
|
September 24, 2021
Combining Thin-Section Coronal and Axial Diffusion Weighted Imaging: Good Practice in Middle Ear Cholesteatoma Neuroimaging
Camilla Russo, Antonella Miriam Di Lullo, Elena Cantone, et al.
Clinical Endocrinology
|
March 1, 2003
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study
Carolina Di Somma, Rosario Pivonello, Sandro Loche, et al.
International Journal of Molecular Sciences
|
December 21, 2017
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer
Adelaide Greco, Luigi Auletta, Francesca Maria Orlandella, et al.
Frontiers in Endocrinology
|
April 2, 2019
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
Michele Klain, Leonardo Pace, Emilia Zampella, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2021
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
Carmela Nappi, Michele Klain, Valeria Cantoni, et al.
Endocrine
|
November 8, 2021
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives
Michele Klain, Julien Hadoux, Carmela Nappi, et al.
Page
of 8